Cogent Biosciences, Inc. (COGT)
NASDAQ·Healthcare·Biotechnology
$35.87
-1.29%
Mkt Cap $5.91B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (19 analysts)
$48.13
Range $35.00 – $60.00
Implied Upside
+34.2%
Consensus $48.13 vs current $35.87
NASDAQ·Healthcare·Biotechnology
$35.87
-1.29%
Mkt Cap $5.91B
Buy
8
Hold
2
Sell
0
Price Target (19 analysts)
$48.13
Range $35.00 – $60.00
+34.2%
Consensus $48.13 vs current $35.87